EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues

Luigi Marano iD, Ludovico Carbone iD, Gianmario Edoardo Poto, Valeria Restaino iD, Stefania Angela Piccioni, Luigi Verre iD, Franco Roviello iD, Daniele Marrelli iD

Current Oncology · 08.01.2023 · 30 (1) · 875-896

DOI: 10.3390/curroncol30010067 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 08.01.2023. Verfasst von Luigi Marano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Surgical Oncology, Department of Medicine Surgery and Neurosciences, University of Siena, 53100 Siena, Italy. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite its decreasing incidence, gastric cancer remains an important global healthcare problem due to its overall high prevalence and high mortality rate. Since the MAGIC and FNLCC/FFCD trials, the neoadjuvant chemotherapy has been recommended throughout Europe in gastric cancer. Potential benefits of preoperative treatments include a higher rate of R0 resection achieved by downstaging the primary tumor, a likely effect on micrometastases and isolated tumor cells in the lymph nodes, and, as a result, improved cancer-related survival. Nevertheless, distortion of anatomical planes of dissection, interstitial fibrosis, and sclerotic tissue changes may increase surgical difficulty. The collection of at least twenty-five lymph nodes after neoadjuvant therapy would seem to ensure removal of undetectable node metastasis and reduce the likelihood of locoregional recurrence. It is not what you take but what you leave behind that defines survival. Therefore, para-aortic lymph node dissection is safe and effective after neoadjuvant chemotherapy, in both therapeutic and prophylactic settings. In this review, the efficacy of adequate lymph node dissection, also in a neoadjuvant setting, has been investigated in the key studies conducted to date on the topic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHumansNeoadjuvant TherapyPrognosisNeoplasm Recurrence, LocalLymph Node Excision

Stichwörter der Autor:innen

gastric cancerlymphadenectomyneoadjuvant

Autor:innen und Institutionen

  • Unit of Surgical Oncology, Department of Medicine Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.

ORCID-Profile: Luigi Marano, Ludovico Carbone, Valeria Restaino, Luigi Verre, Franco Roviello, Daniele Marrelli

Zitieren

APA

Marano, L., Carbone, L., Poto, G. E., Restaino, V., Piccioni, S. A., Verre, L., Roviello, F., & Marrelli, D. (2023). Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues. Current Oncology, 30(1), 875-896. https://doi.org/10.3390/curroncol30010067

Vancouver

Marano L, Carbone L, Poto GE, Restaino V, Piccioni SA, Verre L, et al. Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues. Current Oncology. 2023;30(1):875-896. doi:10.3390/curroncol30010067

BibTeX
@article{Marano2023,
  author = {Marano, Luigi and Carbone, Ludovico and Poto, Gianmario Edoardo and Restaino, Valeria and Piccioni, Stefania Angela and Verre, Luigi and Roviello, Franco and Marrelli, Daniele},
  title = {Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues},
  journal = {Current Oncology},
  year = {2023},
  volume = {30},
  number = {1},
  pages = {875--896},
  doi = {10.3390/curroncol30010067}
}
Kostenlos starten →